OS tissues; adjacent non‐tumour tissues
143B; HOS; MG‐63; SJSA‐1; Saos‐2; U2OS; hFOB 1.19
cell line-derived xenograft
glycolysis (promotes); proliferation (promotes); invasion (promotes); metastasis (promotes); m6A modification (promotes)
Back-Splice Junction PCR / divergent primers PCR; RNase R Treatment; Sanger Sequencing; RT-qPCR; Northern Blot; FISH / smFISH; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; RIP (RNA Immunoprecipitation); RNA Pull-Down; Luciferase Reporter Assay; MeRIP / MeRIP-seq; Actinomycin D / DRB Stability Assay; Transfection; MTT; Colony Formation Assay; Transwell Assay; In Vivo Animal Model; H&E Staining; Survival Analysis; Western Blot; IF (Immunofluorescence)
Upregulated circ‐CTNNB1 was associated with lung metastasis in OS patients.
Circ-CTNNB1 is up-regulated in osteosarcoma and predominantly nuclear. It promotes OS cell growth, invasion and metastasis by binding the m6A writer RBM15 to enhance m6A modification and stabilize/activate glycolysis genes (HK2, GPI, PGK1), thereby driving aerobic glycolysis and tumor progression.
0.8776
Circ-CTNNB1 drives aerobic glycolysis and osteosarcoma progression via m6A modification through interacting with RBM15.
combined biological and clinical study